| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 02/12/2004 | WO2004013144A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/12/2004 | WO2004013141A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 02/12/2004 | WO2004013137A1 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity |
| 02/12/2004 | WO2004012648A2 Substituted diaryl heterocycles, method for the production and use thereof as medicaments |
| 02/12/2004 | WO2003091259A8 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| 02/12/2004 | WO2003088823A3 Novel macrocyclic activatible magnetic resonance imaging contrast agents |
| 02/12/2004 | WO2003070236A3 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/12/2004 | WO2003053561A3 A surfactant assisted nanomaterial generation process |
| 02/12/2004 | WO2003051346A3 Use of selective pde5 inhibitors for treating partial and global respiratory failure |
| 02/12/2004 | WO2003029209A3 Chemical compounds |
| 02/12/2004 | WO2002058698A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 02/12/2004 | US20040029919 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence |
| 02/12/2004 | US20040029915 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof |
| 02/12/2004 | US20040029912 Bicyclic derivatives |
| 02/12/2004 | US20040029900 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidines with a phosphodiesterase v-inhibiting effect |
| 02/12/2004 | US20040029899 Novel compounds |
| 02/12/2004 | US20040029891 Use of PDE5 inhibitors in the treatment of polycystic ovary syndrome |
| 02/12/2004 | US20040029889 Bone disorders; antiarrhythmia agents; cardiovascular disorders |
| 02/12/2004 | US20040029885 New dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| 02/12/2004 | US20040029884 Cyclization in presence of Lawesson's reagent |
| 02/12/2004 | US20040029868 Multiple sclerosis; atherosclerosis; inflamamtory bowel diseases; asthma |
| 02/12/2004 | US20040029866 Polymerase enzyme inhibitors |
| 02/12/2004 | US20040029862 Alzheimer's disease |
| 02/12/2004 | US20040029859 Compounds useful in therapy |
| 02/12/2004 | US20040029746 Wear resistance, oil additive |
| 02/12/2004 | US20040029745 Wear resistance; oil additive |
| 02/12/2004 | US20040029734 Fused-benzene derivatives useful as herbicides |
| 02/12/2004 | DE10233817A1 Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted Diarylheterocyclen, processes for their preparation and their use as medicaments |
| 02/12/2004 | CA2494421A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 02/12/2004 | CA2493637A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/11/2004 | EP1388541A1 Pyrrolopyrazines as kinase inhibitors |
| 02/11/2004 | CN1474821A New cephalotaxanes, their method of preapartion and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapentic agents and reversal agents |
| 02/11/2004 | CN1474820A Benzodiazepine derivatives as GABA A receptor modulators |
| 02/11/2004 | CN1474819A Novel imidazole derivatives, production method thereof and use thereof |
| 02/11/2004 | CN1474818A Preventive or therapeutic medicines for diabetes, containing fused heterocycle compounds or their salts |
| 02/11/2004 | CN1474692A Treatment of premature ejaculation |
| 02/11/2004 | CN1474652A Substituted 4,5-dihydro-1,2,4-triazin -6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides |
| 02/11/2004 | CN1473831A Process for preparing pyrazolo (4,3-d) pyrimidine-7-ketone and its intermediate |
| 02/11/2004 | CN1137893C Synthesis and activity of triazolo-pyrimido-thioacetyl hydrazone compounds |
| 02/10/2004 | US6689883 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 02/10/2004 | US6689881 Method for preparing substituted [1,4]diazepino[6,7,1-hi]indol-4-ones |
| 02/10/2004 | US6689808 Substituted phthalides, a process for their preparations and pharmaceutical compositions containing them |
| 02/10/2004 | US6689804 Imidazo-imidazole |
| 02/10/2004 | US6689290 Family of conducting liquid crystals |
| 02/05/2004 | WO2004011469A1 Cell differentiation inductor |
| 02/05/2004 | WO2004011468A1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 02/05/2004 | WO2004011467A1 Triazolopyrimidine derivatives and fungicides for agricultural and horticultural use |
| 02/05/2004 | WO2004011466A1 NOVEL PROCESS FOR PRODUCING IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVE |
| 02/05/2004 | WO2004011465A1 Kinase inhibitors |
| 02/05/2004 | WO2004011464A2 Novel substituted pyrazolo[1,5 a]-1,3,5-triazine derivatives and their analogues, pharmaceutical compositions containing same, use thereof as medicine and methods for preparing same |
| 02/05/2004 | WO2004011438A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect |
| 02/05/2004 | WO2003080580A3 Quinoline derivatives and their use as 5-ht6 ligands |
| 02/05/2004 | WO2002100886A8 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 02/05/2004 | US20040024211 Such as (3S)-N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-((1S,2S,3S,5R)-2,6,6-trimethylbicyclo(3.1.1)hept-3 -yl)piperazine-1-carboximidamide for treatment of obesity or type II diabetes |
| 02/05/2004 | US20040024043 Administering (-)N-(-)-N phenyl canbamoyleseroline; Alzheimer's disease |
| 02/05/2004 | US20040024001 Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases |
| 02/05/2004 | US20040023997 5-amino-pyrazolo-(4, 3-e)-1,2,4-triazolo(1,5-c)pyrimidine derivatives; treating parkinson's disease and other central nervous system disorders |
| 02/05/2004 | US20040023992 Antiinflammatory agents |
| 02/05/2004 | US20040023991 Use of pyrazolo[4,3-d]pyrimidines |
| 02/05/2004 | US20040023990 Use of pyrazolo[4,3-d]pyrimidines |
| 02/05/2004 | US20040023989 Pyrazolo(4,3-c)piperidine and pyrazolo(4,3-d)pyrimidine derivatives |
| 02/05/2004 | US20040023988 Novel compounds |
| 02/05/2004 | US20040023972 Use of substituted imidazo[1,2-a]-pyridin-, -pyrimidin-and-pyrazin-3-yl-amine derivatives in the preparation of medicaments for inhibiting NOS |
| 02/05/2004 | US20040023971 3,8-Diazabicyclo[3.2.1]octanes and their use in the treatment of cardiac arrhythmias |
| 02/05/2004 | US20040023970 Method for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor in a patient in need thereof which comprises providing to said patient a therapeutically effective amount of a compound of formula I |
| 02/05/2004 | US20040023965 Corticotropin releasing factor antagonists imidazo-triazines of formula I: |
| 02/05/2004 | US20040023964 7-phenylimidazo(1,2-b)(1,2,4)triazine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or bridged by an oxygen atom or a |
| 02/05/2004 | US20040023958 Compounds of formula I are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus. |
| 02/05/2004 | US20040023947 Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
| 02/05/2004 | US20040023946 Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]-pyrazines and decahydropyrazino[1,2-a]azepines |
| 02/05/2004 | US20040023942 Novel, water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases |
| 02/05/2004 | US20040023941 Modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and |
| 02/05/2004 | US20040023927 Bicyclic imidazo-5-yl-amine derivatives |
| 02/05/2004 | US20040023891 Agents for neutron capture therapy |
| 02/05/2004 | US20040023290 Novel therapeutic agents that modulate enzymatic processes |
| 02/05/2004 | US20040023060 Structure including at least three planar moieties, which are linearly configured such that one planar moiety is located between two neighboring planar moieties and shares an atom with each of the moieties |
| 02/05/2004 | US20040022737 Method for using chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
| 02/05/2004 | US20040022734 For therapy of cancer, of fluorescent imaging and optoelectronics |
| 02/05/2004 | US20040021204 Heteroatom-containing diamondoid transistors |
| 02/05/2004 | CA2493924A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect |
| 02/05/2004 | CA2489165A1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 02/04/2004 | EP1386921A1 Intermediates |
| 02/04/2004 | EP1386917A1 Intermediates |
| 02/04/2004 | EP1386912A1 Cyclic amidine derivative |
| 02/04/2004 | EP1386909A1 Cyclopropane amines |
| 02/04/2004 | EP1385854A1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity |
| 02/04/2004 | EP1385849A1 Novel hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| 02/04/2004 | EP1385848A2 Phtalazinones derivatives useful as pde4/7 inhibitors |
| 02/04/2004 | EP1385839A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/04/2004 | EP1385823A1 Novel guanidino compounds |
| 02/04/2004 | EP1385524A1 Pyrazolopyrimidines as therapeutic agents |
| 02/04/2004 | CN1473162A Bicyclic triazolone derivatives and herbicides containing the same |
| 02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
| 02/04/2004 | CN1472212A Substituted carbolnie metal complex and application thereof |
| 02/04/2004 | CN1472211A Biporphin metal coordination compound with bridge linking face-face structure and its use |
| 02/04/2004 | CN1472210A Compound for treating sexual dysfunction |
| 02/04/2004 | CN1472208A Aromatic heterocyclic carboxylic acid derivative, preparing method and application in medicine |
| 02/04/2004 | CN1472198A Continuous preparation of acetylene diureine |
| 02/04/2004 | CN1137123C Azolo triazizes and pyrimidines |
| 02/04/2004 | CN1137100C Tricyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family |